Tilak Mandadi
CIK 1872827 · View on SEC EDGAR ↗
First SEC filing: May 11, 2026 · Latest: May 11, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | CVS | S | 69,551 | $89.58 | $6,230,379 | 10,133 Direct | -87.28% | Disposed | 5.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 31, 2026 | CVS | Stock Option [F3] | Common Stock (143,712) | $71.82 | March 31, 2036 | 143,712 | Acquired |
| April 1, 2025 | CVS | Stock Option [F3] | Common Stock (87,336) | $67.98 | April 1, 2035 | 87,336 | Acquired |
| April 1, 2024 | CVS | Stock Option [F2] | Common Stock (67,920) | $79.56 | April 1, 2034 | 67,920 | Acquired |
| April 1, 2023 | CVS | Stock Option [F2] | Common Stock (96,496) | $74.31 | April 1, 2033 | 96,496 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (1) | — | Feb. 24, 2026 | 1 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (2) | — | Oct. 4, 2025 | 2 | Acquired |
| June 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (6) | — | Aug. 2, 2023 | 6 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (0) | — | Feb. 24, 2026 | 0 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (1) | — | Oct. 4, 2025 | 1 | Acquired |
| March 15, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (5) | — | Aug. 2, 2023 | 5 | Acquired |
| Feb. 24, 2022 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (7,326) | — | Feb. 24, 2026 | 7,326 | Acquired |
| Dec. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (1) | — | Oct. 4, 2025 | 1 | Acquired |
| Dec. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (5) | — | Aug. 2, 2023 | 5 | Acquired |
| Oct. 4, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (22,916) | — | Oct. 4, 2025 | 22,916 | Acquired |
| Sept. 15, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (5) | — | Aug. 2, 2023 | 5 | Acquired |
| Aug. 2, 2021 | MGM | Restricted Stock Units | Common Stock $.01 Par Value ND (75,000) | — | Aug. 2, 2023 | 75,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CVS
Ventures and Chief Experience and Technology Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1,000,000 | — | — | — | $2,561,000 | — | $416,755 | $10,977,716 |
| 2024 | $1,000,000 | — | — | — | $583,000 | — | $278,511 | $11,361,343 |
| 2023 | $1,000,000 | — | $4,874,990 | $1,624,993 | $1,246,000 | — | $135,862 | $8,881,845 |
MGM
Innovation & Technology Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $416,849 | $637,500 | $5,352,750 | — | $956,250 | — | $14,632 | $7,377,981 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.